News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
589,221 Results
Type
Article (48807)
Company Profile (232)
Press Release (540182)
Section
Business (159578)
Career Advice (3076)
Deals (28962)
Drug Delivery (105)
Drug Development (78487)
Employer Resources (176)
FDA (14386)
Job Trends (12626)
News (286401)
Policy (27680)
Tag
Academia (2486)
Alliances (42682)
Alzheimer's disease (1235)
Approvals (14362)
Artificial intelligence (219)
Bankruptcy (251)
Best Places to Work (10373)
Biotechnology (168)
Breast cancer (250)
Cancer (1888)
Cardiovascular disease (125)
Career advice (2583)
CAR-T (140)
Cell therapy (374)
Clinical research (62948)
Collaboration (677)
Compensation (325)
COVID-19 (2540)
C-suite (152)
Data (1634)
Diabetes (183)
Diagnostics (5846)
Earnings (63891)
Employer resources (153)
Events (92585)
Executive appointments (503)
FDA (15258)
Funding (570)
Gene therapy (256)
GLP-1 (660)
Government (4424)
Healthcare (16855)
Infectious disease (2653)
Inflammatory bowel disease (124)
Interviews (618)
IPO (14549)
Job creations (2680)
Job search strategy (2112)
Layoffs (376)
Legal (5231)
Lung cancer (279)
Manufacturing (217)
Medical device (10230)
Medtech (10234)
Mergers & acquisitions (14816)
Metabolic disorders (543)
Neuroscience (1656)
NextGen: Class of 2025 (5737)
Non-profit (4089)
Northern California (2029)
Obesity (295)
Opinion (237)
Patents (154)
People (43448)
Phase I (19921)
Phase II (27845)
Phase III (20612)
Pipeline (773)
Postmarket research (2281)
Preclinical (8493)
Radiopharmaceuticals (257)
Rare diseases (330)
Real estate (4178)
Regulatory (19736)
Research institute (2318)
Resumes & cover letters (498)
Southern California (1735)
Startups (3065)
United States (17378)
Vaccines (637)
Weight loss (220)
Date
Today (99)
Last 7 days (773)
Last 30 days (2658)
Last 365 days (32416)
2025 (4913)
2024 (33238)
2023 (37849)
2022 (48387)
2021 (52204)
2020 (50069)
2019 (41752)
2018 (31647)
2017 (29667)
2016 (28361)
2015 (33079)
2014 (25140)
2013 (20527)
2012 (21173)
2011 (21721)
2010 (19875)
Location
Africa (815)
Asia (39624)
Australia (6699)
California (4583)
Canada (1710)
China (402)
Colorado (202)
Connecticut (215)
Europe (81212)
Florida (639)
Georgia (150)
Illinois (390)
Indiana (236)
Japan (126)
Maryland (722)
Massachusetts (3509)
Michigan (181)
Minnesota (260)
New Jersey (1320)
New York (1338)
North Carolina (775)
Northern California (2029)
Ohio (151)
Pennsylvania (966)
South America (1042)
Southern California (1735)
Texas (655)
Utah (137)
Washington State (459)
589,221 Results for "can fite biopharma ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Can-Fite BioPharma to Present the Namodenoson Anti-Obesity Effect at BIO CEO & Investor Conference 2025
February 5, 2025
·
5 min read
Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024
Can-Fite BioPharma Ltd. announces that its VP of Business Development, Dr. Sari Fishman, will hold 23 partnering meetings with Biotech & Pharma companies, who showed interest in partnering with Can-Fite.
May 27, 2024
·
5 min read
Press Releases
Disappearance of Decompensated Liver Cirrhosis Episodes After Treatment with Can-Fite’s Namodenoson
February 18, 2025
·
6 min read
Drug Development
Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study
Can-Fite BioPharma Ltd. today announced an update on the status of its oncological lead drug candidate, Namodenoson in the treatment of advanced liver cancer.
June 5, 2024
·
6 min read
Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on June 6
Can-Fite BioPharma Ltd. is pleased to invite investors to a webinar on June 6, 2024, at 4:15 p.m. ET.
May 23, 2024
·
5 min read
Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, announces that company scientists came up with breakthrough findings showing that the anti-cancer and protective effects in the liver are conferred via the signalling protein adiponectin.
June 24, 2024
·
6 min read
Business
Can-Fite Reports 2023 Financial Results and Clinical Update
Can-Fite BioPharma Ltd. announced financial results and clinical updates for the twelve months ended December 31, 2023.
March 28, 2024
·
12 min read
Drug Development
Can-Fite Received IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, announced that it received an approval from the Institutional Review Board of Rabin Medical Center, a leading medical institution in Israel where the study will be conducted.
June 10, 2024
·
7 min read
Press Releases
US Patent Office Granted Can-Fite Namodenoson Patent for Use as anti-Obesity Drug
January 27, 2025
·
6 min read
Independent Scientists Published a Review Article Demonstrating That Can-Fite Drugs Have Therapeutic Effects on Heart Diseases
Can-Fite BioPharma Ltd. reported that the International Journal of Molecular Sciences published a scientific review by independent scientists summarizing >50 publications from scientists all over the world stating that piclidenoson and namodenoson have a positive effect on heart diseases.
May 29, 2024
·
5 min read
1 of 58,923
Next
